Contact us to find out how Quality Care Products is more than more than a distribution company.
Market:
- ACO/MSO
- Urgent Care clinics
- Workers Compensation clinics
- Commercial Dispensing Clinics
- Pharmacies
Market:
March 17, 2020
Greetings,
We have a unique responsibility to support our customers and their patients during this public healthcare crisis.
With a critical role supplying the pharmaceuticals urgently needed to respond to coronavirus, as well as to our pharmacies and clinics who dispense acute and chronic medications that their patients also need, QCP has held multiple meetings over the last few weeks to ensure that our customers needs are met in a safe and timely manner, and that our Employees stay safe and healthy.
No slowdown in service has occurred, and none is expected.
QCP’s office workers began working remotely from home last week and will continue to do so until the threat subsides. Workers at our healthcare repackaging, distribution and CSR center continue to report to work.
Thankfully, no employees have been diagnosed with COVID-19, the respiratory disease caused by the novel strain of the virus, and in fact only 1person has been diagnosed in all of Lucas County, at the time of this writing.
QCP has enacted a pre-established plan for responding to a pandemic based on guidelines passed down to us through our lobbying group, Healthcare Distributors Association, from the Centers for Disease Control and Prevention, and the U.S. Department of Health and Human Services, who view the role of QCP and other pharmaceutical Wholesalers as critical to the health and well-being of all Americans.
QCP’s goal has always been to maintain a 3-month supply of over 90% of its’ fast-moving pre-packaged medications. Still, in light of the pandemic, we have increased our supplies of multiple medications and, while we’ve experienced a slight increase in orders as some customers expect that supply chains could be interrupted, we’ve been able to maintain our inventory levels. To date, QCP has experienced zero issues, and the FDA said only 1 medication is in short-supply due to COVID 19. While the possibility of supply disruptions in the future exists, we are communicating with suppliers and customers, and will exhaust all efforts to mitigate any issues that may occur.